OBGYN & Women’s Health

Medically reviewed by Dr. Kimberly Langdon Cull, M.D. on July 25, 2023 The vasomotor symptoms associated with menopause tend to affect women’s quality of life, sleep, and mood. Poor symptom control, treatment dissatisfaction, and negative perceptions of hormone therapy necessitate the implementation of improved management measures.   A substantial percentage of postmenopausal and perimenopausal women experience...

Medically reviewed by Dr. Kimberly Langdon Cull, M.D. on July 25, 2023 Insomnia increases the risk of coronary heart disease. Moreover, insomnia at different ages has a different effect on coronary heart disease risk among menopausal women. The menopausal transition is associated with a myriad of vasomotor and non-vasomotor symptoms. Postmenopausal women also exhibit an...

Medically reviewed by Dr. Kimberly Langdon Cull, M.D. on July 25, 2023 Compared to women without menopausal symptoms, women experiencing vasomotor or non-vasomotor symptoms during the perimenopausal stage tend to have a significantly higher prevalence of poor cardiovascular health metrics. The ideal cardiovascular health (CVH) metrics established by the American Heart Association include diet, cholesterol...

Medically reviewed by Dr. Kimberly Langdon Cull, M.D. on July 25, 2023 Evidence-based research and interactions with physicians mediate the beliefs, use, and perceptions of educated, White, and affluent peri- and postmenopausal women regarding complementary and integrative therapies in treating menopausal symptoms. Menopausal symptoms, including vasomotor and non-vasomotor symptoms, significantly affect the quality of life...

Medically reviewed by Dr. Kimberly Langdon Cull, M.D. on July 25, 2023 Serum levels of anti-Mullerian hormone play an independent role in predicting incident early-onset vasomotor symptoms in premenopausal women. Vasomotor symptoms are cardinal symptoms associated with menopause that negatively influence the quality of life of menopausal women. Early-onset vasomotor symptoms reflect the hormonal fluctuations...

Women with atrial fibrillation and normal baseline cognition had higher risk of disease progression from normal to MCI, MCI to dementia Atrial fibrillation (AF) is associated with increased odds of and with more rapid progression to mild cognitive impairment (MCI) and dementia among women versus men, according to a study published online June 23 in Alzheimer’s...

Both hormonal and non-hormonal therapies are available for treating postmenopausal symptoms. Menopause is the discontinuation of ovarian function and is marked by 12 consecutive months of amenorrhea. It occurs at a median age of 51 years. Postmenopausal symptoms that can be managed include vasomotor symptoms (VMS), vulvovaginal atrophy, sexual dysfunction, dyspareunia, frequent urination, and osteoporosis. ...

Dexamethasone decreases the incidence of docetaxel-induced oral mucositis in patients suffering from breast cancer in a dose-dependent manner. Pharmaceutical formulations containing docetaxel, an effective chemotherapeutic agent for the treatment of breast cancer, commonly lead to the development of oral mucositis (OM). To prevent the fluid retention that is associated with docataxel use in breast cancer...

Psychologically vulnerable breast cancer patients with less education, low social support, low patient activation, and younger age benefited most from nurse navigation intervention. Breast cancer patients with high levels of distress at the time of diagnosis tend to be at risk for physical symptoms and long-term distress. This randomized controlled trial (RCT) evaluated whether breast...